Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity
The formation of neutralizing antibodies is a growing concern in the use of botulinum neurotoxin A (BoNT/A) as it may result in secondary treatment failure. Differences in the immunogenicity of BoNT/A formulations have been attributed to the presence of pharmacologically unnecessary bacterial compon...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2024-02-01
|
| Serie: | Toxins |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2072-6651/16/2/101 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|